Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 210
8
Diseases
60
Unique genes
0.279
Avg. similarity score
Hereditary chronic pancreatitis
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Hereditary chronic pancreatitis
autosomal dominant hypocalcemia 1
familial hypocalciuric hypercalcemia 1
neonatal severe primary hyperparathyroidism
Benign hypercalcemia
Hypocalciuric hypercalcemia
Pancreatitis
Tropical calcific pancreatitis
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Hereditary chronic pancreatitis | 5 | 5 | 8 |
| autosomal dominant hypocalcemia 1 | 5 | 5 | 1 |
| familial hypocalciuric hypercalcemia 1 | 5 | 5 | 1 |
| neonatal severe primary hyperparathyroidism | 5 | 5 | 1 |
| Benign hypercalcemia | 4 | 4 | 2 |
| Hypocalciuric hypercalcemia | 4 | 4 | 3 |
| Pancreatitis | 2 | 2 | 57 |
| Tropical calcific pancreatitis | 2 | 2 | 2 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| CASR | 6 / 8 | autosomal dominant hypocalcemia 1, Benign hypercalcemia, familial hypocalciuric hypercalcemia 1, Hereditary chronic pancreatitis and 2 more |
| CTRC | 3 / 8 | Hereditary chronic pancreatitis, Pancreatitis, Tropical calcific pancreatitis |
| SPINK1 | 3 / 8 | Hereditary chronic pancreatitis, Pancreatitis, Tropical calcific pancreatitis |
| AP2S1 | 2 / 8 | Benign hypercalcemia, Hypocalciuric hypercalcemia |
| CFTR | 2 / 8 | Hereditary chronic pancreatitis, Pancreatitis |
| CPA1 | 2 / 8 | Hereditary chronic pancreatitis, Pancreatitis |
| PRSS1 | 2 / 8 | Hereditary chronic pancreatitis, Pancreatitis |
| PRSS2 | 2 / 8 | Hereditary chronic pancreatitis, Pancreatitis |
| TRPV6 | 2 / 8 | Hereditary chronic pancreatitis, Pancreatitis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Pancreatic secretion | KEGG | 7 / 102 | 13.7× | 6.92e-7 | 3.53e-5 ✓ sig. |
| Bile secretion | KEGG | 6 / 90 | 13.3× | 5.41e-6 | 2.02e-4 ✓ sig. |
| Defective ABCG8 causes gallbladder disease 4 and sitosterolemia | Reactome | 2 / 2 | 200× | 2.45e-5 | 7.07e-4 ✓ sig. |
| Defective ABCG5 causes sitosterolemia | Reactome | 2 / 2 | 200× | 2.45e-5 | 7.07e-4 ✓ sig. |
| ABC transporters | KEGG | 4 / 45 | 17.8× | 7.20e-5 | 1.71e-3 ✓ sig. |
| Neuroactive ligand-receptor interaction | KEGG | 9 / 370 | 4.9× | 8.36e-5 | 1.94e-3 ✓ sig. |
| Interleukin-10 signaling | Reactome | 4 / 47 | 17.0× | 8.55e-5 | 1.97e-3 ✓ sig. |
| Influenza A | KEGG | 6 / 173 | 6.9× | 2.15e-4 | 4.14e-3 ✓ sig. |
| Hormone signaling | KEGG | 6 / 219 | 5.5× | 7.56e-4 | 1.10e-2 ✓ sig. |
| Fat digestion and absorption | KEGG | 3 / 43 | 14.0× | 1.27e-3 | 1.62e-2 ✓ sig. |
| Rheumatoid arthritis | KEGG | 4 / 95 | 8.4× | 1.28e-3 | 1.63e-2 ✓ sig. |
| Type I diabetes mellitus | KEGG | 3 / 44 | 13.6× | 1.36e-3 | 1.71e-2 ✓ sig. |
| Cholesterol metabolism | KEGG | 3 / 51 | 11.8× | 2.08e-3 | 2.35e-2 ✓ sig. |
| Regulation of lipolysis in adipocytes | KEGG | 3 / 59 | 10.2× | 3.16e-3 | 3.20e-2 ✓ sig. |
| Platelet degranulation | Reactome | 4 / 123 | 6.5× | 3.28e-3 | 3.28e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| digestion | GO:0007586 | 4 / 26 | 47.9× | 1.36e-6 | 1.06e-4 ✓ sig. |
| intestinal cholesterol absorption | GO:0030299 | 3 / 11 | 84.9× | 5.10e-6 | 3.06e-4 ✓ sig. |
| negative regulation of intestinal phytosterol absorption | GO:0010949 | 2 / 2 | 311× | 1.01e-5 | 5.27e-4 ✓ sig. |
| negative regulation of intestinal cholesterol absorption | GO:0045796 | 2 / 2 | 311× | 1.01e-5 | 5.27e-4 ✓ sig. |
| adenylate cyclase-activating G protein-coupled receptor signaling pathway | GO:0007189 | 6 / 161 | 11.6× | 1.27e-5 | 6.29e-4 ✓ sig. |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | GO:0007187 | 4 / 54 | 23.1× | 2.69e-5 | 1.13e-3 ✓ sig. |
| cannabinoid signaling pathway | GO:0038171 | 2 / 3 | 208× | 3.04e-5 | 1.23e-3 ✓ sig. |
| negative regulation of synaptic transmission, GABAergic | GO:0032229 | 2 / 4 | 156× | 6.06e-5 | 2.07e-3 ✓ sig. |
| adenylate cyclase-activating G protein-coupled cAMP receptor signaling pathway | GO:0140582 | 2 / 5 | 125× | 1.01e-4 | 3.04e-3 ✓ sig. |
| chemosensory behavior | GO:0007635 | 2 / 6 | 104× | 1.51e-4 | 4.11e-3 ✓ sig. |
| bile acid secretion | GO:0032782 | 2 / 6 | 104× | 1.51e-4 | 4.11e-3 ✓ sig. |
| acute-phase response | GO:0006953 | 3 / 37 | 25.3× | 2.26e-4 | 5.50e-3 ✓ sig. |
| triglyceride homeostasis | GO:0070328 | 3 / 38 | 24.6× | 2.45e-4 | 5.83e-3 ✓ sig. |
| positive regulation of T cell activation | GO:0050870 | 3 / 45 | 20.8× | 4.06e-4 | 8.30e-3 ✓ sig. |
| epidermis development | GO:0008544 | 4 / 114 | 10.9× | 4.92e-4 | 9.45e-3 ✓ sig. |